These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2662045)

  • 21. Economics of epoetin therapy.
    Grimm AM; Flaharty KK; Hopkins LE; Mauskopf J; Besarab A; Vlasses PH
    Clin Pharm; 1989 Nov; 8(11):807-10. PubMed ID: 2509130
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of patients with anemia of malignancy with recombinant human erythropoietin.
    Herrmann F; Oster W; Mertelsmann R
    Contrib Nephrol; 1991; 88():238-45; discussion 246-7. PubMed ID: 2040185
    [No Abstract]   [Full Text] [Related]  

  • 23. A pharmacodynamic model of erythropoietin therapy for uremic anemia.
    Uehlinger DE; Gotch FA; Sheiner LB
    Clin Pharmacol Ther; 1992 Jan; 51(1):76-89. PubMed ID: 1732079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of renal anemia using synthetic human erythropoietin].
    Blumberg A; Zehnder C
    Ther Umsch; 1988 Dec; 45(12):895-9. PubMed ID: 3065970
    [No Abstract]   [Full Text] [Related]  

  • 25. L-Carnitine effects on anemia in uremic rats treated with erythropoietin.
    Azzadin A; Wollny T; Pawlak R; Malyszko JS; Malyszko J; Myśliwiec M; Buczko W
    Nephron; 1999; 83(4):370-1. PubMed ID: 10575305
    [No Abstract]   [Full Text] [Related]  

  • 26. Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin.
    Moia M; Mannucci PM; Vizzotto L; Casati S; Cattaneo M; Ponticelli C
    Lancet; 1987 Nov; 2(8570):1227-9. PubMed ID: 2890852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythropoietin and the myelodysplastic syndrome.
    Jacobs A; Culligan D; Bowen D
    Contrib Nephrol; 1991; 88():266-70. PubMed ID: 2040188
    [No Abstract]   [Full Text] [Related]  

  • 28. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.
    Casati S; Passerini P; Campise MR; Graziani G; Cesana B; Perisic M; Ponticelli C
    Br Med J (Clin Res Ed); 1987 Oct; 295(6605):1017-20. PubMed ID: 3120854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, placebo-controlled clinical trial of recombinant human erythropoietin in the anemia of prematurity.
    Mentzer WC; Shannon KM; Abels RI; Freeman P; Newton N; Thompson D; Phibbs RH
    Contrib Nephrol; 1991; 88():306-12; discussion 313. PubMed ID: 2040193
    [No Abstract]   [Full Text] [Related]  

  • 30. Aluminium interference in the treatment with recombinant human erythropoietin.
    Casati S; Campise M; Ponticelli C
    Contrib Nephrol; 1990; 87():87-94. PubMed ID: 2093544
    [No Abstract]   [Full Text] [Related]  

  • 31. [Factors limiting the correction of anemia with recombinant human erythropoietin].
    Casati S
    Minerva Urol Nefrol; 1991; 43(3):121-3. PubMed ID: 1817332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin: a therapeutic tool.
    Agarwal MB
    J Assoc Physicians India; 1992 Jan; 40(1):9-10. PubMed ID: 1634473
    [No Abstract]   [Full Text] [Related]  

  • 33. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
    Besarab A; McCrea JB
    ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of recombinant human erythropoietin [rHuEpo] in man.
    Adamson JW; Eschbach JW
    Prog Clin Biol Res; 1990; 352():505-17. PubMed ID: 2205875
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
    Desai JD; Shah BV
    J Assoc Physicians India; 1991 Jun; 39(6):483-5. PubMed ID: 1938855
    [No Abstract]   [Full Text] [Related]  

  • 36. Anaphylactic reaction to recombinant human erythropoietin.
    García JE; Senent C; Pascual C; Fernandez G; Perez-Carral C; Diaz-Tejeiro R; Gomez E; Sierra T
    Nephron; 1993; 65(4):636-7. PubMed ID: 8302424
    [No Abstract]   [Full Text] [Related]  

  • 37. Erythropoietin for the anemia of chronic renal failure.
    Schwartz AB; Prior J; Terzian L; Kahn B
    Am Fam Physician; 1988 Jun; 37(6):211-5. PubMed ID: 3289343
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 39. Arterial hypertension in uraemic patients treated with erythropoietin.
    Kokot F; Wiecek A
    Nephron; 1995; 71(2):127-32. PubMed ID: 8569941
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.